title: Attenuation of epithelial injury in acute experimental colitis by immunomodulators.
abstract: Intestinal epithelial permeability can be modulated by the immune system and can be greatly increased by transepithelial migration of neutrophils. Since immunosuppressants have been reported to inhibit the ability of neutrophils to migrate, we assessed the effects of two immunosuppressants on epithelial permeability and granulocyte infiltration in a model of acute colitis. Epithelial permeability was measured at 3 and 6 h after induction of colitis in the rabbit by intracolonic administration of trinitrobenzene sulfonic acid. At these times, blood-to-lumen leakage of 51Cr-EDTA was elevated by approximately 8- and 18-fold, respectively, above levels observed in healthy controls. Pretreatment with either of the immunosuppressants (cyclosporin A and L-683,590) significantly reduced the changes in 51Cr-EDTA leakage observed at the latter time point. These drugs also significantly attenuated granulocyte infiltration of the colon after induction of colitis, as measured by tissue myeloperoxidase activity. Unlike the immunosuppressants, misoprostol, a prostaglandin analogue, attenuated the increases in colonic permeability but had no effect on granulocyte infiltration in this model. These results demonstrate that two structurally unrelated immunosuppressants are capable of markedly reducing neutrophil infiltration and the colonic permeability changes observed in an experimental model of acute colitis, although the mechanisms through which these effects are produced remain unclear.
authors.affiliation: Gastrointestinal Research Group, Faculty of Medicine, University of Calgary, Alberta, Canada.
authors.forename: A
authors.initials: A
authors.lastname: Higa
authors.forename: G W
authors.initials: GW
authors.lastname: McKnight
authors.forename: J L
authors.initials: JL
authors.lastname: Wallace
mesh_terms: D000818:Animals; D003092:Colitis / Q000139:chemically induced / Q000378:metabolism*; D003106:Colon / Q000187:drug effects* / Q000201:enzymology / Q000378:metabolism; D016572:Cyclosporine / Q000008:administration & dosage / Q000494:pharmacology*; D004195:Disease Models, Animal; D004848:Epithelium / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D008297:Male; D016595:Misoprostol / Q000494:pharmacology; D009504:Neutrophils / Q000187:drug effects / Q000502:physiology; D010539:Permeability / Q000187:drug effects; D009195:Peroxidase / Q000378:metabolism; D011817:Rabbits; D016559:Tacrolimus / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000494:pharmacology; D014302:Trinitrobenzenesulfonic Acid
chemical_list: D007166:Immunosuppressive Agents; D016595:Misoprostol; C079136:L 683590; D016572:Cyclosporine; D014302:Trinitrobenzenesulfonic Acid; D009195:Peroxidase; D016559:Tacrolimus